Journal article icon

Journal article

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

Abstract:

PURPOSE: To evaluate the prognostic value of cell of origin immunohistochemical markers and BCL2, BCL6, and c-MYC translocations in a homogeneous cohort of patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). PATIENTS AND METHODS: Patients with CD20+ DLBCL were enrolled in the randomized LNH98-5 and 01-5B Groupe d'Etude des Lymphomes de l'Adulte trials. Paraffin-embedded tumor samples of 119 patie...

Expand abstract

Actions


Access Document


Publisher copy:
10.1200/jco.2009.22.7058

Authors


Copie-Bergman, C More by this author
Gaulard, P More by this author
Expand authors...
Journal:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume:
27
Issue:
33
Pages:
5573-5579
Publication date:
2009-11-05
DOI:
EISSN:
1527-7755
ISSN:
0732-183X
URN:
uuid:e9bfd851-e981-49c1-8222-544677a3fe35
Source identifiers:
246555
Local pid:
pubs:246555

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP